Treatment of locally advanced esophageal cancer with surgery and chemoradiation

Current Opinion in Gastroenterology

Volumn 24, Issue 4, 2008, Pages 535-540

  Siersema, Peter D ^a   Van Hillegersberg, Richard ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Chemoradiation; Esophageal cancer; Esophagectomy; Neoadjuvant therapy; Quality of life

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADJUVANT THERAPY; ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; NUTRITIONAL STATUS; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; REVIEW; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA;

CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; LYMPH NODE EXCISION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT;

EID: 56349153472     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283025ca2     Document Type: Review

References (23)

1. Omloo JM, Lagarde SJ, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/ distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007; 246:992-1001.
2. Chang AC, Ji H, Birkmeyer NJ, et al. Outcomes after transhiatal and trans-thoracic esophagectomy for cancer. Ann Thorac Surg 2008; 85:424-429. Study with data from the SEER database confirming other studies that no overall survival benefit exists for transhiatal or transthoracic esophagectomy in patients with esophageal cancer.
3. DiMusto PD, Orringer MB. Transhiatal esophagectomy for distal and cardia cancers: implications of a positive gastric margin. Ann Thorac Surg 2007; 83:993-999.
4. Barbour AP, Rizk NP, Gonen M, et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 2007; 246:1 -8.
5. Greene FL, Page DL, Fleming ID, editors. American Joint Committee on Cancer. AJCC cancer staging handbook. 6th ed. New York: Springer; 2002.
6. Hofstetter W, Correa AM, Bekele N, et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 2007; 84:365-375. 7 Lagarde SM, Reitsma JB, de Castro SM, et al. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction. Br J Surg 2007; 94:1361-1368.
7. Kumar DharD, Hattori S,Tonomoto Y, et al. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer. Ann Thorac Surg 2007; 83:1265-1272.
8. Shimada H, Shiratori T, Okazumi S, et al. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45years of experience. J Am Coll Surg 2008; 206:48-56.
9. Ruol A, Portale G, Zaninotto G, et al. Results of esophagectomy for esophageal cancer in elderly patients: age has little influence on outcome and survival. J Thorac Cardiovasc Surg 2007; 133:1186-1192.
10. Graham AJ, Shrive FM, Ghali WA, et al. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg 2007; 83:1257-1264.
11. Kim MK, Kim SB, Ahn JH, et al. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 2007; 28 December [Epub ahead of print].
12. Matsuyama J, Doki Y, Yasuda T, et al. The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinomas of the thoracic esophagus. Surgery 2007; 141:570-580.
13. Siewert JR, Lordick F, Ott K, et al. Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome. Ann Surg 2007; 246:624-631.
14. Port JL, Lee PC, Korst RJ, et al. Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma. Ann Thorac Surg 2007; 84:393-400.
15. De Manzoni G, Pedrazzani C, Pasini F, et al. Chemoradiotherapy followed bysurgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. J Surg Oncol 2007; 95:261 -266.
16. Al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 1997; 15:277-284.
17. Wu P, Posner M. The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003; 4:481 -488.
18. Bedenne L, Michel P, Bouche O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25:1160-1168.
19. Gardner-Thorpe J, Hardwick RH, Dwerryhouse SJ. Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg 2007; 94:1059-1066.
20. Di Fiore F, Lecleire S, Pop D, et al. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 2007; 102:2557-2563.
21. Avery KN, Met calfe C, Barham CP, et al. Quality of life during potentially curative treatment for locally advanced oesophageal cancer. Br J Surg 2007; 94:1369-1376.
22. McKernan M, McMillan DC, Anderson JR, et al. The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastrooesophageal cancer. Br J Cancer 2008; 98:888-893.
23. Martin L, Lagergren J, Landbald M, et al. Malnutrition after oesophageal cancer surgery in Sweden. Br J Surg 2007; 94:1496-1500.